UnitedHealth (UNH) stock slips as Senate report puts Medicare Advantage under the microscope
UnitedHealth shares fell 1.9% to $333.93 in after-hours trading Tuesday after a Senate Judiciary Committee report raised concerns about its Medicare Advantage billing. The company denied wrongdoing, saying its practices meet government standards. Investors are watching for UnitedHealth’s 2025 results and 2026 outlook, due Jan. 27.